All Patrick Johnson Articles
-
646Latest Myopia NewsSydnexis Names Nick Ruth as Chief Commercial Officer
SAN DIEGO — Sydnexis Inc., a clinical stage biopharmaceutical company focused on the treatment of progressive myopia in children and minimizing the...
-
832ClinicalSafe and Effective Low-Dose Atropine Can Be Stable and Comfortable Too
sponsored content August 15, 2023 Myopia is the most common eye disease in children and has experienced a dramatic increase in prevalence...